Experiment: 5OQS

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-1H NOESY	20 mM [U-100% 2H] acetic acid, 1.1 mM [U-100% 15N] NFAP, 95 % H2O, 5 % [U-2H] D2O	95% H2O/5% D2O	0.007 M	4.5	1 atm	298	Bruker AVANCE II 700
2	3D 1H-15N NOESY	20 mM [U-100% 2H] acetic acid, 1.1 mM [U-100% 15N] NFAP, 95 % H2O, 5 % [U-2H] D2O	95% H2O/5% D2O	0.007 M	4.5	1 atm	298	Bruker AVANCE II 700
3	3D 1H-13C NOESY aliphatic	1 mM [U-100% 13C; U-100% 15N] NFAP, 20 mM [U-100% 2H] acetic acid, 95 % H2O, 5 % [U-2H] D2O	95% H2O/5% D2O	0.007 M	4.5	1 atm	298	Bruker AVANCE II 700
4	2D 1H-15N HSQC	1 mM [U-100% 13C; U-100% 15N] NFAP, 20 mM [U-100% 2H] acetic acid, 95 % H2O, 5 % [U-2H] D2O	95% H2O/5% D2O	0.007 M	4.5	1 atm	298	Bruker AVANCE II 500
5	2D 1H-13C HSQC	1 mM [U-100% 13C; U-100% 15N] NFAP, 20 mM [U-100% 2H] acetic acid, 95 % H2O, 5 % [U-2H] D2O	95% H2O/5% D2O	0.007 M	4.5	1 atm	298	Bruker AVANCE II 500
13	3D 1H-15N TOCSY	1 mM [U-100% 13C; U-100% 15N] NFAP, 20 mM [U-100% 2H] acetic acid, 95 % H2O, 5 % [U-2H] D2O	95% H2O/5% D2O	0.007 M	4.5	1 atm	298	Bruker AVANCE II 500
12	3D HNCA	1 mM [U-100% 13C; U-100% 15N] NFAP, 20 mM [U-100% 2H] acetic acid, 95 % H2O, 5 % [U-2H] D2O	95% H2O/5% D2O	0.007 M	4.5	1 atm	298	Bruker AVANCE II 500
11	3D HNCACB	1 mM [U-100% 13C; U-100% 15N] NFAP, 20 mM [U-100% 2H] acetic acid, 95 % H2O, 5 % [U-2H] D2O	95% H2O/5% D2O	0.007 M	4.5	1 atm	298	Bruker AVANCE II 500
14	3D HNCO	1 mM [U-100% 13C; U-100% 15N] NFAP, 20 mM [U-100% 2H] acetic acid, 95 % H2O, 5 % [U-2H] D2O	95% H2O/5% D2O	0.007 M	4.5	1 atm	298	Bruker AVANCE II 500
10	3D HN(CO)CA	1 mM [U-100% 13C; U-100% 15N] NFAP, 20 mM [U-100% 2H] acetic acid, 95 % H2O, 5 % [U-2H] D2O	95% H2O/5% D2O	0.007 M	4.5	1 atm	298	Bruker AVANCE II 500
9	3D HNHA	1 mM [U-100% 13C; U-100% 15N] NFAP, 20 mM [U-100% 2H] acetic acid, 95 % H2O, 5 % [U-2H] D2O	95% H2O/5% D2O	0.007 M	4.5	1 atm	298	Bruker AVANCE II 500
8	3D HN(COCA)CB	1 mM [U-100% 13C; U-100% 15N] NFAP, 20 mM [U-100% 2H] acetic acid, 95 % H2O, 5 % [U-2H] D2O	95% H2O/5% D2O	0.007 M	4.5	1 atm	298	Bruker AVANCE II 500
7	3D HN(CA)CO	1 mM [U-100% 13C; U-100% 15N] NFAP, 20 mM [U-100% 2H] acetic acid, 95 % H2O, 5 % [U-2H] D2O	95% H2O/5% D2O	0.007 M	4.5	1 atm	298	Bruker AVANCE II 500
6	3D HCCH-TOCSY	20 mM [U-100% 2H] acetic acid, 1.1 mM [U-100% 15N] NFAP, 95 % H2O, 5 % [U-2H] D2O	95% H2O/5% D2O	0.007 M	4.5	1 atm	298	Bruker AVANCE II 500

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE II	500
2	Bruker	AVANCE II	700

NMR Refinement
Method	Details	Software
simulated annealing		CARA
torsion angle dynamics		CYANA

NMR Ensemble Information
Conformer Selection Criteria	all calculated structures submitted
Conformers Calculated Total Number	20
Conformers Submitted Total Number	20
Representative Model	9 (medoid)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	chemical shift assignment	CARA	1.9.0	Keller and Wuthrich
2	structure calculation	CYANA	2.1	Guntert, Mumenthaler and Wuthrich
3	refinement	TALOS	+	Cornilescu, Delaglio and Bax
4	processing	TopSpin	3.0	Bruker Biospin

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.